Douglas F. Larson

Current heart failure therapeutics affects symptoms without appreciably reducing the mortality rate of 50% in five years – suggesting a failure in treating the underlying mechanism. This book proposes a new mechanism for heart failure; immune mediate…

Current heart failure therapeutics affects symptoms without appreciably reducing the mortality rate of 50% in five years – suggesting a failure in treating the underlying mechanism. This book proposes a new mechanism for heart failure; immune mediate…